Logo

American Heart Association

  112
  0


Final ID: P2083

Lower Your LDL Cholesterol Now Initiative: Understanding Survivor LDL Awareness and Behaviors

Abstract Body: Introduction: High cholesterol, and specifically high low-density lipoprotein cholesterol (LDL-C), is one of the major controllable risk factors for coronary heart disease, heart attack and stroke. About 1 in 4 U.S. adults have high LDL-C, which can be caused by lifestyle risk factors or genetics. More investigation is needed to understand the appropriate educational approach on LDL-C with heart attack and stroke survivors.

Goals: The American Heart Association (AHA) is implementing a national 3-year initiative called Lower Your LDL Cholesterol NowTM to improve LDL-C understanding, testing and treatment adherence among survivors. We aim to understand survivors’ knowledge, motivators, and barriers to cholesterol testing and treatment to ultimately build an educational approach, supportive of cholesterol self-management skills.

Methods: A 15-minute online survey was conducted with The Harris Poll on behalf of the AHA among nationally representative sample of 3,008 U.S. adults aged 18+ and an oversample of 503 U.S. adults aged 18+ who have experienced and survived a heart attack and/or stroke.

Results: The survey revealed three out of four survivors (75%) reported having high cholesterol yet nearly half (47%) are unaware of their LDL-C number. Additionally, only about half (49%) prioritize their cholesterol, and 1 in 3 believe high cholesterol poses no or only a small increased risk for heart attack and stroke. However, 98% of survivors are willing to get their cholesterol measured if recommended by their health care professional (HCP).

Conclusion: Nearly all survivors are receptive to having their cholesterol checked by their HCP if recommended, therefore, this initiative will focus on educating survivors to 1) know their LDL-C number, 2) understand the connection between high LDL and repeat events and 3) improve treatment adherence.
  • Yuan, Meg  ( American Heart Association , Dallas , Texas , United States )
  • Dunn, Mary  ( American Heart Association , Dallas , Texas , United States )
  • Collins, Eliana  ( American Heart Association , Dallas , Texas , United States )
  • Wielgopolan, Jamie  ( American Heart Association , Dallas , Texas , United States )
  • Author Disclosures:
    Meg Yuan: DO NOT have relevant financial relationships | Mary Dunn: DO NOT have relevant financial relationships | Eliana Collins: No Answer | Jamie Wielgopolan: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

PS02.09 Lipids and Lipoproteins

Friday, 03/07/2025 , 05:00PM - 07:00PM

Poster Session

More abstracts on this topic:
A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) Particles

Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John

Abdominal Circumference and Coronary Calcium Score in a Healthy Nonobese Brazilian Cohort: ELSA-Brasil Cohort Analysis

Correa Fabiano Ronaldo, Bittencourt Marcio, Bosco Mendes Thiago, Romero-nunez Carlos, Generoso Giuliano, Staniak Henrique, Foppa Murilo, Santos Raul, Lotufo Paulo, Bensenor Isabela

More abstracts from these authors:
Lipoprotein (a) Discovery Project: Assessing Patient and Professional Education Needs

Yuan Meg, Groom Allison, Collins Eliana, Peña David, Colson Kristin, Skinner Jeremy, Congdon Michelle, Pressley Alyssa

Telehealth Experiences and Preferences Among Patients with Cardiovascular Disease Risk Factors

Tep Allison, Jones Olivia, Cherkur Sruthi, Yuan Meg, Beastrom Carly, Mathew Cristin

You have to be authorized to contact abstract author. Please, Login
Not Available